Journal of the American Chemical Society · 2016 · 215 citations · 31 references
Life SciencesInfectious DiseasesMicrobiologyAntimicrobial PharmacologyDrug DeliveryMicrobial EcologyAntibacterial PharmacologyAntimicrobial TherapyBacterial BiofilmsBiofilm FormationBiofilm Formation In InfectionMicrobial BiofilmsAnti-biofilm StrategiesBiofilm InhibitionBiofilm InhibitorsBiofilm-associated InfectionsBiofilm-disrupting AgentsChemical Inhibition Of BiofilmsInhibitors Of Biofilm FormationQuaternary Ammonium Compounds
It is estimated that up to 80% of bacterial infections are accompanied by biofilm formation. Since bacteria in biofilms are less susceptible to antibiotics than are bacteria in the planktonic state, biofilm-associated infections pose a major health threat, and there is a pressing need for antibiofilm agents. Here we report that water-soluble cationic pillararenes differing in the quaternary ammonium groups efficiently inhibited the formation of biofilms by clinically important Gram-positive pathogens. Biofilm inhibition did not result from antimicrobial activity; thus, the compounds should not inhibit growth of natural bacterial flora. Moreover, none of the cationic pillararenes caused detectable membrane damage to red blood cells or toxicity to human cells in culture. The results indicate that cationic pillararenes have potential for use in medical applications in which biofilm formation is a problem.
31
The EPS Matrix: The “House of Biofilm Cells”
Hans‐Curt Flemming, Thomas R. Neu, Daniel J. Wozniak · Journal of Bacteriology · 2007 · 1.8K citations · Full text
Pillararenes, A New Class of Macrocycles for Supramolecular Chemistry
Min Xue, Yong Yang, Xiaodong Chi et al. · Accounts of Chemical Research · 2012 · 1.4K citations
A genetic basis for Pseudomonas aeruginosa biofilm antibiotic resistance
Thien‐Fah Mah, Betsey Pitts, Brett J. Pellock et al. · Nature · 2003 · 1.2K citations